info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
Home » Healthcare » Non-Invasive Ventilators Market Size, Global Report, 2030

Non-Invasive Ventilators Market By Type (Continuous Positive Airway Pressure (CPAP), Bilevel Positive Pressure (BiPAP), Autotitrating (Adjustable) Positive Airway Pressure (APAP)), By Application (Respiratory Distress Syndrome, Asthma & COPD, Others), By End-User (Ambulatory Surgical Centers, Hospitals and Clinics, Others), By Geography, Size, Trends and Growth Forecast, 2021-2030

Published On: Jun-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2015 - 2019   |   Formats: PDF   |   Report ID: 86121348

Industry Report and Statistics (Facts & Figures) - Sales Volume, Procedure & ASP by Product, Application & End-users
 

The global non-invasive ventilators market size was $1.70 Billion in 2021 and is predicted to reach $2.84 Billion by 2030, representing a CAGR of 5.9% during the forecast period 2021-2030.

A ventilator is a machine that facilitates oxygen delivery to the lungs. When an individual can breathe on his/her own, it helps them to breathe. Mechanical ventilation is the process of assisting breathing with a ventilator that is attached to our nose through a pipe-like structure. Mechanical ventilation can be Positive-pressure ventilation (pushes the air into the lungs) or Negative-pressure ventilation (sucks the air into the lungs through a device).

 

Non-Invasive Ventilators Market by Infographic

 

Types of Positive Pressure Ventilation: Positive ventilation are of two types;

  • Non-Invasive ventilation (NIV): In this, the delivery of positive pressure ventilation is done through a Non Invasive interface (like a nasal mask, face mask, or nasal plugs). In NIV, the air is delivered through a sealed mask placed over the mouth, nose or whole face.

  • Invasive ventilation: In this, the air is delivered via a tube inserted into the windpipe through the mouth or sometimes the nose using an invasive interface (endotracheal tube, tracheostomy).

non invasive ventilators market by share 2020-2030

Types of NIV: There are three types of Non-Invasive Positive-Pressure ventilation

  • Continuous Positive Airway Pressure (CPAP): a constant flow of pressurized room air is provided via a face mask. The pressure setting of this airflow is often determined by a doctor based on the patient's need.

  • Bilevel Positive Pressure (BiPAP): The BiPAP machine can alternate between two pressures that allow breathing in with higher pressure and breathing out against a slightly lower pressure. Bilevel may be required when pressures are higher to improve comfort, especially at PAP pressures that are 15cm of water pressure or higher.

  • Autotitrating (Adjustable) Positive Airway Pressure (APAP): It changes pressure all night based on our breathing patterns. It has even more features to maintain normal breathing in sleep. It can vary the volume of air delivered and the speed at which the lungs are inflated and deflated.

 

Uses: Non Invasive ventilation offers the following advantages:

  • It reduces the work pressure on the lungs.

  • It eliminates the need for endotracheal intubation or a tracheotomy.

  • It reduces the chances of infections and enhances the survival rate.

  • It reduces the hospital stay.

  • Helps in assisted spontaneous breathing (pressure-controlled).

 

Applications: Non Invasive ventilators find various applications to treat various diseases like

 

Chronic Obstructive Pulmonary Disease: A chronic inflammatory lung disease that leads to obstructed airflow from the lungs. It includes Long-term diseases like chronic bronchitis and emphysema, in which excessive coughing, increased respiratory rate and difficulty breathing.

 

Resuscitation: While controlled mechanical ventilation is most frequently used during cardiopulmonary resuscitation (CPR), Continuous Positive Airway Pressure ventilation is a promising alternative approach for reducing peak airway pressures and, therefore, a potential enhancement in the haemodynamics.

 

Cardiogenic pulmonary Edema: Increased cardiac pressures cause fluid to accumulate in the lungs. Heart failure is frequently the cause. 

 

Respiratory muscle weakness: A potentially life-threatening condition where persistent incapacity of respiratory muscles to generate sufficient pressure.

 

Ventilator-associated pneumonia: It is a lung infection that develops in a person who is on a ventilator.

 

Sleep Apnea: A sleep disorder in which breathing repeatedly stops and starts.

 

COVID-19: An infectious disease caused by the SARS-CoV-2 virus.

 

Market Dynamics

Drivers (High incidences of chronic conditions, Increasing intensive care admissions, Growing pollution levels and Unhealthy lifestyles)

High incidences of chronic conditions:  A chronic condition is a human health condition or disease whose symptoms are persistent or long-lasting or a sickness that develops over time. A chronic condition usually affects multiple body areas, is not fully responsive to treatment, and persists for an extended period. The CDC (Centers for Disease Control and Prevention) findings suggest that 51.8% of the adults in America had at least one chronic condition, & nearly 27.2% suffer from multiple chronic cases. The prevalence was highest among women, non-Hispanic white adults, adults over 65 or older, and those residing in rural areas.

 

Increasing intensive care admissions: Intensive care is appropriate for patients requiring or likely to require advanced respiratory support, patients requiring the support of two or more organ systems, and patients with chronic impairment of one or more organ systems which also require support for an acute reversible failure of another organ. Over 5 million patients are admitted to ICUs in the United States every year for invasive and intensive monitoring, airway support, breathing, or circulation, stabilization of various life-threatening medical problems, thorough management of injury or illness, & increase in the comfort level for dying patients, according to the Society of Critical Care Medicine (SCCM).

 

Growing pollution levels: Heart disease, stroke, lung cancer, lower respiratory infections, Diabetes, and Chronic Obstructive Pulmonary Disease are linked to air pollution (outdoor and indoor particulate matter and ozone). Air pollution is third among the world's main causes of mortality, according to the Global Burden of Disease study report (2019). Air pollution caused 6.82 million annual fatalities worldwide, with indoor air pollution accounting for 34% and outdoor air pollution accounting for 66%.

 

Unhealthy lifestyles: The rise in the adoption of unhealthy lifestyles, such as smoking, Which is one of the major contributors to the growth of the Non-Invasive Ventilators market. Other drivers include irregular sleep patterns, alcohol, tobacco consumption and second-hand smoke that develop into respiratory problems. The findings in the Global Burden of Disease Study (GBD 2019) estimate that tobacco use (8.7 million), smoking (7.7 million) and second-hand smoke (1.3 million) account for nearly 18 million deaths every year.

non invasive ventilators market by type 2020-2030

Restraints (High cost and Risk of Ventilator-Associated Pneumonia)

High cost: Due to limited treatment and care options available to patients who suffer from COPD, they face frequent hospitalization that bears high costs. According to the American Thoracic Society (ATS), the ventilation system costs include $4,298 for devices, $10,805 for doctor visits, $758 for medication, and $8,598 for treatment of exacerbations.

 

Risk of Ventilator-Associated Pneumonia: Ventilator-associated pneumonia is pneumonia that develops after a patient has been intubated and given mechanical ventilation for more than 48 hours. Micro-aspiration of bacteria that colonize the oropharynx and upper airways in critically ill patients is the most common cause of ventilator-associated pneumonia. According to an article published in NCBI, Nearly 86% of nosocomial pneumonia is associated with mechanical ventilation and is termed ventilator-associated pneumonia (VAP). Between 250,000 and 300,000 cases annually occur in the United States, with an incidence rate of 5 to 10 cases per 1,000 hospital admissions.

 

Opportunities 

Technological advancements: Innovation in the area of positive airway pressure (PAP) systems, portability, and improvement in battery life are paving the way for operating efficiency. The portable ventilator market is showing sharp growth due to the high demand for ventilators compatible with different settings like remote medical facilities, ambulances, and homecare due to various life-threatening diseases. There is a surge in the Research work done on the different modes of ventilation like Assist/Control ventilation (A/C), Pressure Support Ventilation (PSV) and Synchronized Intermittent Mandatory Ventilation (SIMV).

 

Increasing old age population: Several body changes happen as you get older that may cause a decline in lung capacity: Alveoli can lose their shape and become baggy. The diaphragm can become weaker in due course of time, thus decreasing the ability to inhale & exhale. Pulmonary disease has significant consequences for the ageing population. According to the findings of the American Lung Association, Most (86%) Chronic Obstructive Pulmonary Disease deaths occur among those aged 65 years or older.

 

Rising obesity and Diabetes: Obesity and overweight pose a major risk for chronic diseases and are considered as major risk factors for the development of lung disease. Obesity leads to mechanical compression of the diaphragm, chest and lungs cavity, causing restrictive pulmonary damage. Similarly, Diabetes also affects lung functioning as blood glucose levels increase.

 

Global Non-Invasive Ventilators Market Segments Analysis

The industry has been segmented based on Type, Application, End-user, and Region.

By Type

  • Continuous Positive Airway Pressure (CPAP)

  • Bilevel Positive Pressure (BiPAP)

  • Autotitrating (Adjustable) Positive Airway Pressure (APAP)

 

By Application

  • Respiratory Distress Syndrome

  • Asthma & COPD

  • Others

 

By End-User

  • Ambulatory Surgical Centers

  • Hospitals and Clinics

  • Others

 

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • The Middle East and Africa

non invasive ventilators market by region 2020-2030

By Type, the Continuous Positive Airway Pressure (CPAP) segment dominates the industry share as it is used most often because its the simplest, most effective and most extensively studied treatment for sleep apnea.

 

By application, COPD and Asthma segment leads the global non-invasive ventilators market. COPD & Bronchial asthma is an obstructive pulmonary disease affecting millions of people worldwide. COPD is a leading cause of chronic mortality & morbidity, as well as a prominent public health issue around the world. According to the article published in NCBI, globally, 300 million people are affected by COPD and up to 300 million by asthma. COPD is associated with an estimated 3 million deaths per year and asthma with 200,000 deaths per year.

 

By End-user, the Hospitals and Clinics segment is expected to contribute the highest share in the global Non Invasive ventilator market. There are a host of causes for a patient with Chronic Obstructive Pulmonary Disease to be hospitalized, ranging from pneumonia to infection. The most common reason is a COPD exacerbation, a change in breathing symptoms beyond the normal day-to-day variation. According to Eurostat (2019), On average, in-patients with diseases of the respiratory system had to spent between 5.1 days (Sweden) and 10.5 days (Czechia) at the hospital.

 

By region, North America dominates the industry due to the presence of leading manufacturers, increasing chronic respiratory diseases, rising healthcare expenditure, various collaborations and new product launches. The Asia Pacific is anticipated to witness the fastest growth over the forecast period. According to American Lung Association, 16.4 

Million people in the US (6.6%) adults reported a diagnosis of any COPD (chronic bronchitis or emphysema).

 

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 1.70 Billion

The revenue forecast in 2030

USD 2.84 Billion

Growth rate

CAGR of 5.90%

The base year for estimation

2021

Historical data

2015 – 2021

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

Product Type, Application, End-user, and Region.

By Product type

Continuous Positive Airway Pressure (CPAP), Bilevel Positive Pressure (BiPAP) and Autotitrating (Adjustable) Positive Airway Pressure (APAP)

By Application

COPD/Asthma, Respiratory Distress Syndrome and Others

By End- User

Hospitals/Clinics, Ambulatory Surgical Centers and Others

By Region

North America, Europe, Asia Pacific, Latin America the Middle East & Africa.

Country Scope

US, Mexico, Canada, Germany, UK, France, China, Japan, India etc.

Company Usability Profiles

O-Two Medical Technologies Inc., ResMed Inc., Hamilton Bonaduz AG, Teleflex Incorporated, HEYER Medical AG, WILAmed GmbH, Airon Corporation, Fisher & Paykel Healthcare, Magnamed, medin Medical Innovations GmbH, Respironics, Inc., Phoenix Medical Systems Pvt. Ltd., Mindray Medical International Limited, Smiths Medical, Inc., etc.

 

Non-Invasive Ventilators Market Competitive Landscape Analysis:

The report has the competitive landscape analysis, which details the most significant competitors operating in a global industry. Overall revenue generation, market initiatives, company overview, R&D investment, production analysis, value chain optimization, industry share financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, and other variables are used to make comparisons in the industry analysis.

 

Key Players currently dominating the industry are:  

 

Recent Developments

  • In June 2022, Inspiration Healthcare received a £1.3 million order from Iraq for SLE ventilators and Viomedex consumables. The SLE ventilators are sophisticated newborn ventilators with a wide range of traditional modes as well as Non Invasive ventilation (NIV), high-frequency oscillation ventilation (HFOV), and high flow oxygen treatment. They are widely used to treat premature and ill babies in Neonatal Intensive Care Units worldwide.

 

  • In January 2022, Philips Respironics issued a recall for certain Trilogy Evo ventilators with particular serial numbers due to potential health hazards. A Philips supplier utilized non-conforming polyester-based polyurethane (PE-PUR) sound abatement foam in the muffler assembly of the concerned Trilogy Evo ventilators. The polyester-based polyurethane (PE-PUR) sound abatement foam used to minimize sound and vibration in these devices may degrade and enter the devices air channel. Trilogy Evo ventilator delivers persistent or intermittent positive pressure breathing for paediatric to adult patients who require mechanical ventilation and weigh approx. 2.5 kg.

 

  • The ventilator can measure, display, record, and alarm saturation level of oxygen (SpO2), a fraction of inspired oxygen (FiO2), CO2 and pulse rate data when integrated with the desired accessories. The ventilator is apt for home, institutional, & non-emergency transport settings, for example, in a wheelchair or personal vehicle that can be utilized for invasive and Non Invasive ventilation.

 

  • In November 2021, Luisa, an advanced ventilator intended for use in homes, institutions, hospitals, or portable applications for invasive and Non Invasive ventilation, was commercially launched in the United States by Movair, a formerly known respiratory therapy company as International Biophysics Corporation. Luisa is a lightweight and compact home ventilator that is one of the first to include high-flow oxygen therapy. Luisa, weighing under eight pounds and having a powerful life of up to 18 hours, provides patients with eight customizable comfort settings for personalized, tailored therapy. Luisa also has a rotating 10-inch display and a variety of connectivity choices, allowing patients to incorporate the ventilator into their daily routines, such as sleeping on one side of the bed.

 

  • In November 2020, Philips Ventilator BiPAP A40 EFL was introduced by Royal Philips, a global pioneer in health technology. Philips extends its homecare solutions with a new ventilation therapy feature for Chronic Obstructive Pulmonary Disease sufferers to breathe easier with the launch of this Non Invasive ventilator. Pulmonologists may now recognize COPD patients with expiratory flow restriction (EFL) and treat them with targeted medication to alleviate symptoms and improve sleep quality. The BiPAP A40 EFL ventilator controls pressure constantly and optimally based on the patient's needs.

 

Various Products that key market leaders develop:

Product

Function

Key players

V60

Microprocessor-controlled, bilevel positive airway pressure (BiPAP) ventilatory assist system.

Phillips Healthcare

AirCurve 10 ST-A

It delivers useful Non Invasive ventilation for patients with respiratory insufficiency such as restrictive lung disorders, hypoventilation syndromes, neuromuscular disease, and severe COPD.

Resmed Inc

Oxymag

Top-end portable, emergency, post-recovery transport ventilator with 5.7″ touch screen.

Magnamed

pNeuton

Mini Ventilator for Neonatal / Infant critical life support.

Airon Corporation

Protector Airway

A laryngeal mask airway (LMA) device that is put behind the mouth and nose and connects to the food pipe (pharynx) to allow ventilation, oxygenation, and anaesthetic gas administration without needing a tube in the windpipe.

Teleflex

Frequently Asked Question About This Report

Key players in the NIV ventilators market include ResMed Inc., Teleflex Incorporated, Hamilton Bonaduz AG, HEYER Medical AG, Respironics, Inc., Airon Corporation, Fisher & Paykel Healthcare, Magnamed, medin Medical Innovations GmbH, Phoenix Medical Systems Pvt. Ltd., Smiths Medical, Inc., O-Two Medical Technologies Inc., WILAmed GmbH, Mindray Medical International Limited, and others.

The global non-invasive ventilators market size was $1.70 Billion in 2021 and is predicted to reach $2.84 Billion by 2030 with a CAGR of 5.9%.

Non-Invasive ventilators market forecasts the Asia-Pacific region with the highest growth rate.

The global non-invasive ventilators market is expected to grow at a compound annual growth rate (CAGR) of 5.9% from 2021 to 2030 to reach $2.84 Billion by 2030.

North America has the largest share in the Non-Invasive Ventilation Market.

.

1.   Introduction

       1.1. Study Objective

       1.2. Market Definition        

       1.3. Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1. Data Procurement

       2.2. Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

   2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3. Market Size Estimation

       2.4. Bottom-Up and Top-Down Approaches

              2.4.1.     Bottom-Up Approach

                     2.4.1.1.         Approach for arriving at Market size by bottom-up analysis

              2.4.2.     Top-Down Approach

                     2.4.2.1.         Approach for Capturing Market Size by Top-Down Analysis

       2.5. Market Breakdown and Data Triangulation

       2.6. Research Methodology

       2.7. Risk Assessment

3.  Executive Summary

       3.1 Non-Invasive Ventilators Market: Post-Covid-19

              3.1.1      Actual Scenario

              3.1.2      Pessimistic Scenario

              3.1.3      Optimistic Scenario

              3.1.4      Market Summary

4. Industry Outlook

       4.1 Market Snapshot

       4.2 Non-Invasive Ventilators Market

              4.2.1       Market, 2021-2030 (USD Million)

       4.3 Regional Business Analysis

              4.3.1       Market, by region, 2021-2030 (USD Million)

       4.4 By Type Business Analysis

              4.4.1       Market, By Type, 2021-2030 (USD Million)

       4.5 By End-User Business Analysis

              4.5.1       Market, By End-User, 2021-2030 (USD Million)

       4.6 Application Business Analysis

              4.6.1       Market, By Application, 2021-2030 (USD Million)

       4.7 Value Chain Analysis

       4.8 Market Variable Analysis

              4.8.1      Market Drivers Analysis

              4.8.2      Market Restraints Analysis

       4.9Business Environment Analysis Tool

              4.9.1      Market PEST analysis

              4.9.2      Market Porter’s analysis

       4.10Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1. Introduction

       5.2. Market Dynamics

              5.2.1.     Drivers

              5.2.2.     Restraints

              5.2.3.     Opportunities

              5.2.4.     Challenges

       5.3. Impact of Covid-19 On Market

       5.4. Value Chain Analysis

       5.5. Ecosystem

       5.6. Patent Analysis

       5.7. Trade Analysis

       5.8. Tariff Analysis

       5.9. Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1    Threat of New Entrants

              5.10.2    Threat of Substitutes

              5.10.3    Bargaining Power of Buyers

              5.10.4    Bargaining Power of Suppliers

              5.10.5    Degree of Competition

       5.11.              Application Analysis

              5.11.1.   Trends in Application (2014-2020)

              5.11.2.   Trends in Application (2021-2028)

       5.12.              Pricing Analysis

              5.12.1.   Average Price Trend Analysis (By Region, By Countries)

6. Competitive & Vendor Landscape

       6.1. Company Market Share Analysis

       6.2. Manufacturers Manufacturing Sites, Area Served, Product  Type

       6.3. Market Competitive Situation and Trends

       6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Market: By Type Segment Analysis

       7.1. Introduction

       7.2. Sales Volume & Revenue Analysis (2021-2030)

       7.3. Continuous Positive Airway Pressure (CPAP)

              7.3.1. Continuous Positive Airway Pressure (CPAP), 2021-2030 (USD Million)

       7.4. Bilevel Positive Pressure (BiPAP)

              7.4.1. Bilevel Positive Pressure (BiPAP) Market, 2021-2030 (USD Million)

       7.5. Autotitrating (Adjustable) Positive Airway Pressure (APAP)

              7.5.1. Autotitrating (Adjustable) Positive Airway Pressure (APAP) Market, 2021-2030 (USD Million)

8.   Market: By End-User Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Ambulatory Surgical Centers

              8.3.1.     Ambulatory Surgical Centers Market, 2021-2030 (USD Million)

       8.4. Hospitals and Clinics

              8.4.1.     Hospitals and Clinics Market, 2021-2030 (USD Million)

       8.5. Others

              8.5.1.     Others Market, 2021-2030 (USD Million)

9.   Market: By Application Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. Respiratory Distress Syndrome

              9.3.1.     Respiratory Distress Syndrome Market, 2021-2030 (USD Million)

       9.4. Asthma & COPD

              9.4.1.     Asthma & COPD Market, 2021-2030 (USD Million)

       9.5. Others

              9.5.1.     Others Market, 2021-2030 (USD Million)

10.   Market: Regional Outlook

10.1 North America

              10.1.1.   North America Market, By Type, 2021-2030 (USD Million)

              10.1.2.   North America Market, By End-User, 2021-2030 (USD Million)

              10.1.3.   North America Market, by Application, 2021-2030 (USD Million)

              10.1.4.   North America Market, by Country, 2021-2030 (USD Million)

       10.1.4.1. U.S.

                     10.1.4.1.1.   U.S.  Market, By Type, 2021-2030 (USD Million)

                     10.1.4.1.2.   U.S.  Market, By End-User, 2021-2030 (USD Million)

                     10.1.4.1.3.   U.S.  Market, by Application, 2021-2030 (USD Million)

10.1.4.2. Canada

                     10.1.4.2.1.   Canada Market, By Type, 2021-2030 (USD Million)

                     10.1.4.2.2.   Canada Market, By End-User, 2021-2030 (USD Million)

                     10.1.4.2.3.   Canada Market, by Application, 2021-2030 (USD Million)

10.2. Europe

              10.2.1.   Europe Market, By Type, 2021-2030 (USD Million)

              10.2.2.   Europe Market, By End-User, 2021-2030 (USD Million)

              10.2.3.   Europe Market, by Application, 2021-2030 (USD Million)

              10.2.4.   Europe Market, by country, 2021-2030 (USD Million)

10.2.4.1    U.K.

                     10.2.4.1.1.   U.K.  Market, By Type, 2021-2030 (USD Million)

                     10.2.4.1.2.   U.K.  Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.1.3.   U.K.  Market, by Application, 2021-2030 (USD Million)

10.2.4.2.              Germany

                     10.2.4.2.1.   Germany Market, By Type, 2021-2030 (USD Million)

                     10.2.4.2.2.   Germany Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.2.3.   Germany Market, by Application, 2021-2030 (USD Million)

10.2.4.3.              France

                     10.2.4.3.1.   France Market, By Type, 2021-2030 (USD Million)

                     10.2.4.3.2.   France Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.3.3.   France Market, by Application, 2021-2030 (USD Million)

10.2.4.4.              Rest of Europe

                     10.2.4.4.1.   Rest of Europe Market, By Type, 2021-2030 (USD Million)

                     10.2.4.4.2.   Rest of Europe Market, By End-User, 2021-2030 (USD Million)

                     10.2.4.4.3.   Rest of Europe Market, by Application, 2021-2030 (USD Million)

       10.3.              Asia Pacific

              10.3.1.   Asia Pacific Market, By Type, 2021-2030 (USD Million)

              10.3.2.   Asia Pacific Market, By End-User, 2021-2030 (USD Million)

              10.3.3.   Asia Pacific Market, by Application, 2021-2030 (USD Million)

              10.3.4.   Asia Pacific Market, by country, 2021-2030 (USD Million)

10.3.4.1.              China

                     10.3.4.1.1.   China Market, By Type, 2021-2030 (USD Million)

                     10.3.4.1.2.   China Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.1.3.   China Market, by Application, 2021-2030 (USD Million)

10.3.4.2.              India

                     10.3.4.2.1.   India Market, By Type, 2021-2030 (USD Million)

                     10.3.4.2.2.   India Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.2.3.   India Market, by Application, 2021-2030 (USD Million)

10.3.4.3.              Japan

                     10.3.4.3.1.   Japan Market, By Type, 2021-2030 (USD Million)

                     10.3.4.3.2.   Japan Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.3.3.   Japan Market, by Application, 2021-2030 (USD Million)

10.3.4.4.              South Korea

                     10.3.4.4.1.   South Korea Market, By Type, 2021-2030 (USD Million)

                     10.3.4.4.2.   South Korea Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.4.3.   South Korea Market, by Application, 2021-2030 (USD Million)

10.3.4.5.              Rest of ASIA PACIFIC

                     10.3.4.5.1.   Rest of ASIA PACIFIC Market, By Type, 2021-2030 (USD Million)

                     10.3.4.5.2.   Rest of ASIA PACIFIC Market, By End-User, 2021-2030 (USD Million)

                     10.3.4.5.3.   Rest of ASIA PACIFIC Market, by Application, 2021-2030 (USD Million)

       10.4.              Latin America

              10.4.1.   Latin America Market, By Type, 2021-2030 (USD Million)

              10.4.2.   Latin America Market, By End-User, 2021-2030 (USD Million)

              10.4.3.   Latin America Market, by Application, 2021-2030 (USD Million)

              10.4.4.   Latin America Market, by country, 2021-2030 (USD Million)

10.4.4.1.              Brazil

                     10.4.4.1.1.   Brazil Market, By Type, 2021-2030 (USD Million)

                     10.4.4.1.2.   Brazil Market, By End-User, 2021-2030 (USD Million)

                     10.4.4.1.3.   Brazil Market, by Application, 2021-2030 (USD Million)

10.4.4.2.              Mexico

                     10.4.4.2.1.   Mexico Market, By Type, 2021-2030 (USD Million)

                     10.4.4.2.2.   Mexico Market, By End-User, 2021-2030 (USD Million)

                     10.4.4.2.3.   Mexico Market, by Application, 2021-2030 (USD Million)

                     10.4.4.3.       Rest of Latin America

                     10.4.4.3.1.   Rest of the Latin America Market, By Type, 2021-2030 (USD Million)

                     10.4.4.3.2.   Rest of the Latin America Market, By End-User, 2021-2030 (USD Million)

                     10.4.4.3.3.   Rest of the Latin America Market, by Application, 2021-2030 (USD Million)

       10.5.              MEA

              10.5.1.   MEA Market, By Type, 2021-2030 (USD Million)

              10.5.2.   MEA Market, By End-User, 2021-2030 (USD Million)

              10.5.3.   MEA Market, by Application, 2021-2030 (USD Million)

              10.5.4.   MEA Market, by Region, 2021-2030 (USD Million)

 

11. Competitive Landscape

11.1 ResMed Inc 

              11.1.1.   Company overview

              11.1.2.   Financial performance

              11.1.3.   ProductPortfolio Analysis

              11.1.4.   Business Strategy & Recent Development

11.2. TELEFLEX INCORPORATED

              11.2.1.   Company overview

              11.2.2.   Financial performance

              11.2.3.   Product Portfolio Analysis

              11.2.4.   Business Strategy & Recent Development

11.3. HAMILTON BONADUZ AG

              11.3.1.   Company overview

              11.3.2.   Financial performance

              11.3.3.   Product Portfolio Analysis

              11.3.4.   Business Strategy & Recent Development

11.4. HEYER MEDICAL AG

              11.4.1.   Company overview

              11.4.2.   Financial performance

              11.4.3.   Product Portfolio Analysis

              11.4.4.   Business Strategy & Recent Development

11.5. RESPIRONICS

              11.5.1.   Company overview

              11.5.2.   Financial performance

              11.5.3.   Product Portfolio Analysis

              11.5.4.   Business Strategy & Recent Development

11.6. Airon Corporation

              11.6.1.   Company overview

              11.6.2.   Financial performance

              11.6.3.   Product Portfolio Analysis

              11.6.4.   Business Strategy & Recent Development

11.7. Fisher & Paykel Healthcare

              11.7.1.   Company overview

              11.7.2.   Financial performance

              11.7.3.   Product Portfolio Analysis

              11.7.4.   Business Strategy & Recent Development

11.8. Magnamed

              11.8.1.   Company overview

              11.8.2.   Financial performance

              11.8.3.   Product Portfolio Analysis

              11.8.4.   Business Strategy & Recent Development

11.9. Medin Medical Innovations GmbH

              11.9.1.   Company overview

              11.9.2.   Financial performance

              11.9.3.   Product Portfolio Analysis

              11.9.4.   Business Strategy & Recent Development

11.10. Mindray Medical International Limited

              11.10.1. Company overview

              11.10.2. Financial performance

              11.10.3. Product Portfolio Analysis

              11.10.4. Business Strategy & Recent Development

11.11. O-Two Medical Technologies Inc

              11.11.1. Company overview

              11.11.2. Financial performance

              11.11.3. Product Portfolio Analysis

              11.11.4. Business Strategy & Recent Development

11.12. Phoenix Medical Systems Pvt. Ltd

              11.12.1. Company overview

              11.12.2. Financial performance

              11.12.3. Product Portfolio Analysis

              11.12.4. Business Strategy & Recent Development

11.13. Phillips Healthcare

              11.13.1. Company overview

              11.13.2. Financial performance

              11.13.3. Product Portfolio Analysis

              11.13.4. Business Strategy & Recent Development

11.14. Smiths Medical

              11.14.1. Company overview

              11.14.2. Financial performance

              11.14.3. Product Portfolio Analysis

              11.14.4. Business Strategy & Recent Development

11.15. WILAmed GmbH

              11.15.1. Company overview

              11.15.2. Financial performance

              11.15.3. Product Portfolio Analysis

              11.15.4. Business Strategy & Recent Development

 

List of Tables (59 Tables)

TABLE 1.   Market, By Type, 2021-2030 (USD Million)

TABLE 2.   Market FOR Continuous Positive Airway Pressure (CPAP), BY REGION, 2021-2030 (USD Million)

TABLE 3.   Market FOR Bilevel Positive Pressure (BiPAP), BY REGION, 2021-2030 (USD Million)

TABLE 4.   Market FOR Autotitrating (Adjustable) Positive Airway Pressure (APAP), BY REGION, 2021-2030 (USD Million)

TABLE 5.  Market, By End-User, 2021-2030 (USD Million)

TABLE 6.  Market FOR Ambulatory Surgical Centers, BY REGION, 2021-2030 (USD Million)

TABLE 7.  Market FOR Hospitals and Clinics, BY REGION, 2021-2030 (USD Million)

TABLE 8.  Market FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 9.  Market, BY APPLICATION, 2021-2030 (USD Million)

TABLE 10.  Market FOR Respiratory Distress Syndrome, BY REGION, 2021-2030 (USD Million)

TABLE 11.  Market FOR Asthma & COPD, BY REGION, 2021-2030 (USD Million)

TABLE 12.  Market FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 13.  Market, BY REGION, 2021-2030 (USD Million)

TABLE 14. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 15. NORTH AMERICA Market, By Type, 2021-2030 (USD Million)

TABLE 16. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million)

TABLE 17. NORTH AMERICA Market, BY APPLICATION, 2021-2030 (USD Million)

TABLE 18. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 19. EUROPE Market, By Type, 2021-2030 (USD Million)

TABLE 20. EUROPE Market, By End-User, 2021-2030 (USD Million)

TABLE 21. EUROPE Market, BY APPLICATION, 2021-2030 (USD Million)

TABLE 22. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 23. ASIA-PACIFIC Market, By Type, 2021-2030 (USD Million)

TABLE 24. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million)

TABLE 25. ASIA-PACIFIC Market, BY APPLICATION, 2021-2030 (USD Million)

TABLE 26. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 27. LAMEA Market, By Type, 2021-2030 (USD Million)

TABLE 28. LAMEA Market, By End-User, 2021-2030 (USD Million)

TABLE 29. LAMEA Market, BY APPLICATION, 2021-2030 (USD Million)

TABLE 30. ResMed Inc: COMPANY SNAPSHOT

TABLE 31. ResMed Inc: OPERATING SEGMENTS

TABLE 32. TELEFLEX INCORPORATED: COMPANY SNAPSHOT

TABLE 33. TELEFLEX INCORPORATED: OPERATING SEGMENTS

TABLE 34. HAMILTON BONADUZ AG: COMPANY SNAPSHOT

TABLE 35. HAMILTON BONADUZ AG: OPERATING SEGMENTS

TABLE 36. HEYER MEDICAL AG: COMPANY SNAPSHOT

TABLE 37. HEYER MEDICAL AG: OPERATING SEGMENTS

TABLE 38. RESPIRONICS: COMPANY SNAPSHOT

TABLE 39. RESPIRONICS: OPERATING SEGMENTS

TABLE 40. Airon Corporation: COMPANY SNAPSHOT

TABLE 41. Airon Corporation: OPERATING SEGMENTS

TABLE 42. Fisher & Paykel Healthcare: COMPANY SNAPSHOT

TABLE 43. Fisher & Paykel Healthcare: OPERATING SEGMENTS

TABLE 44. Magnamed: COMPANY SNAPSHOT

TABLE 45. Magnamed: OPERATING SEGMENTS

TABLE 46. Medin Medical Innovations GmbH: COMPANY SNAPSHOT

TABLE 47. Medin Medical Innovations GmbH: OPERATING SEGMENTS

TABLE 48. Mindray Medical International Limited: COMPANY SNAPSHOT

TABLE 49. Mindray Medical International Limited: OPERATING SEGMENTS

TABLE 50. O-Two Medical Technologies Inc: COMPANY SNAPSHOT

TABLE 51. O-Two Medical Technologies Inc: OPERATING SEGMENTS

TABLE 52. Phoenix Medical Systems Pvt. Ltd: COMPANY SNAPSHOT

TABLE 53. Phoenix Medical Systems Pvt. Ltd: OPERATING SEGMENTS

TABLE 54. Phillips Healthcare: COMPANY SNAPSHOT

TABLE 55. Phillips Healthcare: OPERATING SEGMENTS

TABLE 56. Smiths Medical: COMPANY SNAPSHOT

TABLE 57. Smiths Medical: OPERATING SEGMENTS

TABLE 58. WILAmed GmbH: COMPANY SNAPSHOT

TABLE 59. WILAmed GmbH: OPERATING SEGMENTS                

 

List of Figures (22 Figures)

Figure 1 Non-Invasive Ventilators Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries:  Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Market: Product-Based Estimation

Figure 6 Top 15 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Non-Invasive Ventilators, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Non-Invasive Ventilators, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Market, By End-User, 2019 vs 2025 (USD Million)

Figure 12 Market Share, By Application, 2019 vs 2025 (USD Million)

Figure 13 Market Share, By Type, 2019 vs 2025 (USD Million)

Figure 14 Geographical Snapshot of the Market

Figure 15 Continuous Positive Airway Pressure (CPAP) 5kgto Witness Higher CAGR in Market for Type Segment during Forecast Period.

Figure 16 Asthma & COPD to Witness Higher CAGR in Market for Application Segment during Forecast Period.

Figure 17 Hospitals and Clinics to Witness Higher CAGR in the Market for End-User Segment during Forecast Period.

Figure 18 North America Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019

Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges

Figure 20 North America:  Market Snapshot

Figure 21 Asia Pacific:  Market Snapshot

Figure 22 Vendor Dive: Evaluation Overview